Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Bladder01:23

Urinary Bladder

The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taking the 'HIT' (Heparin-induced thrombocytopenia) - Balancing Local Testing with Delayed Central Results.

Irish medical journal·2026
Same author

Impact of a trauma bypass protocol on a receiving Emergency Department: a 4-year review.

Irish medical journal·2025
Same author

Sex Difference in the Association between Prior Fracture and Subsequent Risk of Incident Dementia: A Longitudinal Cohort Study.

The journal of prevention of Alzheimer's disease·2024
Same author

The Semon Lectures and the foundation of modern ENT.

The Journal of laryngology and otology·2021
Same author

Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study): a superiority randomised clinical trial to evaluate the effectiveness and cost-effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms.

Trials·2021
Same author

Antidiuretic hormone inhibits osteogenic differentiation of dental follicle stem cells via V1a receptors and the PLC-IP<sub>3</sub> pathway.

Archives of oral biology·2021

Related Experiment Video

Updated: Jul 13, 2026

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation
08:08

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation

Published on: August 21, 2012

Bladder afferent sensitivity in wild-type and TRPV1 knockout mice.

D Daly1, W Rong, R Chess-Williams

  • 1University of Sheffield, Department of Biomedical Science, Western Bank, Sheffield S10 2TN, UK.

The Journal of Physiology
|July 14, 2007
PubMed
Summary

The transient receptor potential vanilloid 1 (TRPV1) channel plays a key role in bladder afferent sensitivity, particularly in low-threshold fibers. This finding suggests TRPV1 as a potential therapeutic target for lower urinary tract disorders.

More Related Videos

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

A Decentralized (Ex Vivo) Murine Bladder Model with the Detrusor Muscle Removed for Direct Access to the Suburothelium during Bladder Filling
06:36

A Decentralized (Ex Vivo) Murine Bladder Model with the Detrusor Muscle Removed for Direct Access to the Suburothelium during Bladder Filling

Published on: November 28, 2019

Related Experiment Videos

Last Updated: Jul 13, 2026

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation
08:08

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation

Published on: August 21, 2012

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

A Decentralized (Ex Vivo) Murine Bladder Model with the Detrusor Muscle Removed for Direct Access to the Suburothelium during Bladder Filling
06:36

A Decentralized (Ex Vivo) Murine Bladder Model with the Detrusor Muscle Removed for Direct Access to the Suburothelium during Bladder Filling

Published on: November 28, 2019

Area of Science:

  • Neuroscience
  • Urology
  • Molecular Biology

Background:

  • Understanding bladder afferent pathways is crucial for developing therapies for lower urinary tract disorders like overactive bladder and cystitis.
  • The transient receptor potential vanilloid 1 (TRPV1) ion channel is a potential candidate molecule involved in bladder function.
  • Previous studies suggest TRPV1 channels may influence the detection of bladder filling, impacting micturition thresholds.

Purpose of the Study:

  • To investigate the role of TRPV1 receptors in controlling bladder afferent sensitivity in mice.
  • To utilize pharmacological blockade and genetic deletion of TRPV1 to assess its function in bladder afferent pathways.

Main Methods:

  • Recorded multiunit afferent activity in vitro from bladder afferents of wild-type (TRPV+/+) and TRPV1 knockout (TRPV1-/-) mice.
  • Administered the TRPV1 antagonist capsazepine to wild-type preparations.
  • Assessed bladder afferent responses to mechanical distension, intravesical hydrochloric acid, and capsaicin in both genotypes.

Main Results:

  • Ramp bladder distension in wild-type mice produced a graded increase in afferent activity.
  • Capsazepine significantly attenuated afferent discharge in wild-type mice.
  • Afferent responses to distension were significantly attenuated in TRPV1-/- mice, with blunted sensitivity to acid and capsaicin. Low-threshold afferent responses were reduced in TRPV1-/- mice, while high-threshold sensitivity remained unchanged.

Conclusions:

  • TRPV1 channels play a significant role in the excitability of bladder afferents, especially low-threshold fibers.
  • The study demonstrates a clear role for TRPV1 in bladder afferent sensitivity, independent of changes in bladder compliance.
  • TRPV1 emerges as a potential therapeutic target for managing lower urinary tract disorders by modulating bladder afferent function.